Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma

Clinical trial NCT07627698 · RECRUITING

Trial details

NCT number: NCT07627698
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unresectable Melanoma Metastatic Cutaneous Melanoma Metastatic Uveal Melanoma

Start date: 2026-03-02
Primary completion: 2027-06-14
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.